Cart (0 Items)
Your cart is currently empty.
View ProductsSize | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Stable Isotope Labelled Guselkumab Biosimilar - Anti-IL23A mAb - Research Grade |
---|---|
Source | CAS 1350289-85-8 |
Species | Homo sapiens |
Expression system | Mammalian cells |
Molecular weight | 143kDa |
Purity | >95% |
Buffer | PBS buffer PH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery Time | 3-5 days if in stock; 5-8 weeks if production needed |
Storage condition | store at -80°C |
Brand | ProteoGenix |
Applications | MS |
Aliases /Synonyms | CNTO-1959 |
Reference | PX-TA1327-SIL |
Related Products | PX-P5123 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IgG1-lambda |
Clonality | Monoclonal Antibody |
Format | Lyophilized |
Labelling | Arginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99% |
Isotopic Enrichment | 99% |
Stability | 1 year |
Guselkumab is a human IgG1? monoclonal antibody that targets interleukin-23. IL-23 is an inflammatory cytokine that is reponsible for the activation of the CD4+ T-helper (Th17) cell pathway in the inflammatory cascade that induces psoriatic plaque formation. Guselkumab has been used to treat psoriasis. It has been sold under the trade name Tremfya.
Reviews
Il n’y a pas encore d’avis.